Millions of overweight Americans have begun taking Qnexa, an obesity drug that increases the chances of birth defects and heart problems in those who take it.
Regulators are working to develop restrictive standards to exclude pregnant women from taking the drug and hope to provide a training program for physicians and limit distribution of the pill to certified mail order pharmacies.
Related Articles on GI and Endoscopy:
Dr. Joseph Brasco: 5 Points on Fecal Microbiota Transplant in an ASC
Stony Brook University Medical Center Opens New Bariatric and Metabolic Center
Chronic Kidney Disease Patients Can Safely Undergo Bariatric Surgery, Study Says
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
